Sign In
Buy CRSP
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
Can Casgevy Deliver a Turnaround for CRISPR Therapeutics?
08:26am, Thursday, 19'th Jun 2025
CRSP bets on Casgevy to drive growth, but its extremely high price tag and slow rollout test investor patience in a crowded field.
CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know
06:50pm, Wednesday, 18'th Jun 2025
The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $44.43, representing a +2.87% change from its previous close.
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Wednesday, 18'th Jun 2025
Zacks.com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Can a $10,000 Investment in CRISPR Therapeutics Turn Into $1 Million?
06:34am, Sunday, 15'th Jun 2025
CRSP's innovative pipeline shines, but the biotech does face regulatory risks and fierce competition.
Crispr Therapeutics: Betting On A One-Shot Future
06:27pm, Friday, 13'th Jun 2025
Crispr Therapeutics AG is transitioning to a commercial company, with CASGEVY's rollout and a robust pipeline in cardiovascular, autoimmune, and oncology driving long-term potential. The cardiovascula
Biotech Stock for Options Bears to Target Right Now
02:41pm, Wednesday, 11'th Jun 2025
Biotech stock Crispr Therapeutics Inc's (NASDAQ:CRSP) June rally appears to be coming to an end.
CRISPR Therapeutics Gains 14% in a Month: How to Play the Stock?
11:35am, Wednesday, 11'th Jun 2025
CRSP surges 14% on encouraging CTX310 data and growing Casgevy sales, despite early-stage pipeline risks.
CRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key Facts
06:56pm, Tuesday, 10'th Jun 2025
The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $42.94, representing a +2.02% change from its previous close.
CRISPR Therapeutics AG (CRSP) Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)
05:50pm, Monday, 09'th Jun 2025
CRISPR Therapeutics AG (NASDAQ:CRSP ) Goldman Sachs 46th Annual Global Healthcare Conference June 9, 2025 3:20 PM ET Company Participants Samarth Kulkarni - CEO & Chairman Conference Call Participants
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know
10:00am, Friday, 06'th Jun 2025
CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
CRISPR Therapeutics (CRSP) Up 11.1% Since Last Earnings Report: Can It Continue?
12:37pm, Thursday, 05'th Jun 2025
CRISPR Therapeutics (CRSP) reported earnings 30 days ago. What's next for the stock?
Can CRISPR Build on Casgevy's Success With Its In Vivo Pipeline?
09:56am, Wednesday, 04'th Jun 2025
CRSP aims to extend its gene-editing lead with in vivo candidates after Casgevy's ex vivo breakthrough success.
CRISPR Therapeutics AG (CRSP) William Blair's 45th Annual Growth Stock Conference (Transcript)
04:07pm, Tuesday, 03'rd Jun 2025
CRISPR Therapeutics AG (NASDAQ:CRSP ) William Blair's 45th Annual Growth Stock Conference June 3, 2025 12:20 PM ET Company Participants Raju Prasad - Chief Financial Officer Conference Call Participan
The Best Stocks to Invest $1,000 in Right Now
04:30am, Tuesday, 03'rd Jun 2025
Are you just as afraid of a market pullback right now as you are of missing out on upside? If so, you're not alone.
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
08:30am, Thursday, 29'th May 2025
ZUG, Switzerland and BOSTON, May 29, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseas
